Similar articles

• DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector.

  Tähtinen M, Strengell M, Collings A, Pitkänen J, Kjerrström A, Hakkarainen K, Peterson P, Kohleisen B, Wahren B, Ranki A, Ustav M, Krohn K. Tähtinen M, et al. Vaccine. 2001 Feb 28;19(15-16):2039-47. doi: 10.1016/s0264-410x(00)00420-5. Vaccine. 2001. PMID: 11228375
• Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.

  Calarota SA, Kjerrström A, Islam KB, Wahren B. Calarota SA, et al. Hum Gene Ther. 2001 Sep 1;12(13):1623-37. doi: 10.1089/10430340152528129. Hum Gene Ther. 2001. PMID: 11535166 Clinical Trial.
• Nucleic acid vaccination with HIV regulatory genes.

  Wahren B, Hinkula J, Ståhle EL, Borrebaeck CA, Schwartz S, Wigzell H. Wahren B, et al. Ann N Y Acad Sci. 1995 Nov 27;772:278-81. doi: 10.1111/j.1749-6632.1995.tb44759.x. Ann N Y Acad Sci. 1995. PMID: 8546408 No abstract available.
• Retroviral vectors for HIV immunotherapy.

  Warner JF, Jolly D, Mento S, Galpin J, Haubrich R, Merritt J. Warner JF, et al. Ann N Y Acad Sci. 1995 Nov 27;772:105-16. doi: 10.1111/j.1749-6632.1995.tb44736.x. Ann N Y Acad Sci. 1995. PMID: 8546383 Review. No abstract available.
• Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review).

  Menéndez-Arias L, Mas A, Domingo E. Menéndez-Arias L, et al. Viral Immunol. 1998;11(4):167-81. doi: 10.1089/vim.1998.11.167. Viral Immunol. 1998. PMID: 10189185 Review.